World Health Organization (WHO) Risk Level Reductions in Inpatients With Alcohol Use Disorder and Comorbid Anxiety Disorders

被引:0
|
作者
Stevenson, Brittany L. [1 ,3 ]
Anker, Justin [1 ]
Thuras, Paul [2 ]
Rinehart, Linda [1 ]
Kushner, Matt G. [1 ]
机构
[1] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN USA
[2] Minneapolis Vet Affairs, One Vet Dr, Minneapolis, MN USA
[3] Univ Minnesota, Dept Psychiat & Behav Sci, 2450 Riverside Ave, Minneapolis, MN 55454 USA
关键词
harm reduction; inpatient; alcohol use disorder; alcohol dependence; treatment outcomes; CONTROLLED DRINKING; GOAL CHOICE; DEPENDENCE; CONSUMPTION; THERAPY;
D O I
10.1037/adb0000895
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Studies have demonstrated that reduced drinking without total abstinence is associated with improved outcomes in outpatients with alcohol use disorder (AUD). We sought to examine this question in AUD inpatients who have comorbid anxiety disorders, a common presentation in AUD. Method: This is a secondary analysis of data from a randomized controlled trial for N = 241 inpatients with AUD and comorbid anxiety disorders. Change from baseline drinking level was measured at 1-, 4-, and 12-months postdischarge, and psychological and functional outcomes were measured at 4- and 12-months postdischarge. Three groups were compared: abstinent, reduced (reduced drinking by 1-3 World Health Organization drinking risk levels without abstinence), or nonreduced (maintained or increased drinking risk level). Results: At 1-, 4-, and 12-months posttreatment, most patients reported abstinence (83, 63, and 60%), and 11, 25, and 26% reported drinking at a reduced level. Drinking reductions achieved at 1-month posttreatment were maintained at 12-month posttreatment by 74% of participants. Overall, the abstinent group reported the best psychological and functional outcomes at follow-ups, followed by the reduced group. Few differences were observed between reducers and nonreducers, but reducers reported significantly better alcohol dependence severity and alcohol-related problems than nonreducers. Conclusions: Though abstinence was associated with the best outcomes in this abstinence-based treatment sample, we conclude that reduced drinking is also associated with significant improvements in alcohol-related outcomes in inpatients with AUD and comorbid anxiety disorders. Public Health Significance Statement The results of this study indicate that reducing one's drinking by one to three WHO risk levels following inpatient treatment is associated with beneficial alcohol-related outcomes (e.g., fewer alcohol-related problems) at 1-year posttreatment. However, abstinence was associated with larger improvement in psychological outcomes than reducing drinking, as well as some functional outcomes (e.g., more days of work, fewer interpersonal problems).
引用
收藏
页码:713 / 722
页数:10
相关论文
共 50 条
  • [31] Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder
    Megan Kirouac
    Elizabeth R. Stein
    Matthew R. Pearson
    Katie Witkiewitz
    Quality of Life Research, 2017, 26 : 2987 - 2997
  • [32] Efficacy of the Unified Protocol for the treatment of comorbid alcohol use and anxiety disorders: Study protocol and methods
    Farchione, Todd J.
    Fitzgerald, Hayley E.
    Curreri, Andrew
    Janes, Amy C.
    Gallagher, Matthew W.
    Sbi, Sophia
    Eustis, Elizabeth H.
    Barlow, David H.
    CONTEMPORARY CLINICAL TRIALS, 2021, 108
  • [33] World Health Organization Risk Drinking Levels Among Mandated College Students: Associations With Alcohol Use, Mental Health, and Academic Performance
    Reid, Allecia E.
    Cho, Grace Y.
    Carey, Kate B.
    Witkiewitz, Katie
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2024, 85 (04) : 522 - 527
  • [34] Comorbid Alcohol and Cannabis Use Disorders Among High-Risk Youth at Intake Into Residential Care
    Mason, W. Alex
    Chmelka, Mary B.
    Howard, Brigid K.
    Thompson, Ronald W.
    JOURNAL OF ADOLESCENT HEALTH, 2013, 53 (03) : 350 - 355
  • [35] Social anxiety disorder is a risk factor for alcohol use problems in the National Comorbidity Surveys
    Rosenstrom, Tom H.
    Torvik, Fartein Ask
    DRUG AND ALCOHOL DEPENDENCE, 2023, 249
  • [36] TREATING INPATIENTS WITH COMORBID DEPRESSION AND ALCOHOL USE DISORDERS: A COMPARISON OF ACCEPTANCE AND COMMITMENT THERAPY VERSUS TREATMENT AS USUAL
    Petersen, Connie L.
    Zettle, Robert D.
    PSYCHOLOGICAL RECORD, 2009, 59 (04): : 521 - 536
  • [37] Randomised controlled trial of integrated cognitive behavioural treatment and motivational enhancement for comorbid social anxiety and alcohol use disorders
    Stapinski, Lexine A.
    Sannibale, Claudia
    Subotic, Mirjana
    Rapee, Ronald M.
    Teesson, Maree
    Haber, Paul S.
    Baillie, Andrew J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (02): : 207 - 220
  • [38] The relationship between social anxiety disorder and alcohol use disorders: A critical review
    Morris, EP
    Stewart, SH
    Ham, LS
    CLINICAL PSYCHOLOGY REVIEW, 2005, 25 (06) : 734 - 760
  • [39] Explaining the association between anxiety disorders and alcohol use disorder: A twin study
    Torvik, Fartein Ask
    Rosenstrom, Tom Henrik
    Gustavson, Kristin
    Ystrom, Eivind
    Kendler, Kenneth S.
    Bramness, Jorgen G.
    Czajkowski, Nikolai
    Reichborn-Kjennerud, Ted
    DEPRESSION AND ANXIETY, 2019, 36 (06) : 522 - 532
  • [40] Treatment for Comorbid Borderline Personality Disorder and Alcohol Use Disorders: A Review of the Evidence and Future Recommendations
    Gianoli, Mayumi O.
    Jane, J. Serrita
    O'Brien, Erin
    Ralevski, Elizabeth
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2012, 20 (04) : 333 - 344